Brown Barry W
Department of Biostatistics and Applied Mathematics, Unit 237, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Genet Res. 2004 Apr;83(2):133-41. doi: 10.1017/s0016672304006743.
The transmission/disequilibrium test (TDT) and the affected sib pair test (ASP) both test for the association of a marker allele with some conditions. Here, we present methods for calculating the probability of detecting the association (power) for a study examining a fixed number of families for suitability for the study and for calculating the number of such families to be examined. Both calculations use a genetic model for the association. The model considered posits a bi-allelic marker locus that is linked to a bi-allelic disease locus with a possibly nonzero recombination fraction between the loci. The penetrance of the disease is an increasing function of the number of disease alleles. The TDT tests whether the transmission by a heterozygous parent of a particular allele at a marker locus to an affected offspring occurs with probability greater than 0.5. The ASP tests whether transmission of the same allele to two affected sibs occurs with probability greater than 0.5. In either case, evidence that the probability is greater than 0.5 is evidence for association between the marker and the disease. Study inclusion criteria (IC) can greatly affect the necessary sample size of a TDT or ASP study. IC considered by us include a randomly selected parent at least one parent or both parents required to be heterozygous. It also allows a specified minimum number of affected offspring to be required (TDT only). We use elementary probability calculations rather than complex mathematical manipulations or asymptotic methods (large sample size approximations) to compute power and requisite sample size for a proposed study. The advantages of these methods are simplicity and generality.
传递/不平衡检验(TDT)和患病同胞对检验(ASP)均用于检验标记等位基因与某些疾病状况之间的关联性。在此,我们提出了一些方法,用于计算在一项针对固定数量家庭进行适用性研究时检测到这种关联性的概率(检验效能),以及计算需要检验的此类家庭的数量。这两种计算都使用了一种用于关联性的遗传模型。所考虑的模型假设有一个双等位基因标记位点,它与一个双等位基因疾病位点相连,两个位点之间的重组率可能不为零。疾病的外显率是疾病等位基因数量的递增函数。TDT检验杂合子父母将标记位点上的特定等位基因传递给患病后代的概率是否大于0.5。ASP检验将相同等位基因传递给两个患病同胞的概率是否大于0.5。在任何一种情况下,概率大于0.5的证据都表明标记与疾病之间存在关联。研究纳入标准(IC)会极大地影响TDT或ASP研究所需的样本量。我们考虑的IC包括随机选择的父母、至少一方父母或双方父母必须是杂合子。它还允许要求有指定的最小数量的患病后代(仅适用于TDT)。我们使用基本概率计算,而非复杂的数学运算或渐近方法(大样本量近似)来计算拟进行研究的检验效能和所需样本量。这些方法的优点是简单性和通用性。